Literature DB >> 4032590

Overflow urinary incontinence due to carbamazepine.

R J Anders, E Wang, J Radhakrishnan, R Sharifi, M Lee.   

Abstract

We describe the first well documented case of overflow urinary incontinence owing to prolonged carbamazepine treatment for temporal lobe seizures. Carbamazepine increased the bladder capacity to 1,700 ml. and was accompanied by symptoms of urgency and frequency. After carbamazepine was discontinued and the patient was given primidone the voiding symptoms disappeared. Post-voiding catheterization of the bladder showed minimal residual urine volume. In a review of urological adverse reactions of anticonvulsant drugs that are effective in the management of temporal lobe seizures we found that only primidone and phenobarbital have not been convincingly associated with such side effects. However, phenytoin and clonazepam have been linked with urinary incontinence, and valproic acid with enuresis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032590     DOI: 10.1016/s0022-5347(17)47428-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Associations of commonly used medications with urinary incontinence in a community based sample.

Authors:  Susan A Hall; May Yang; Margaret A Gates; William D Steers; Sharon L Tennstedt; John B McKinlay
Journal:  J Urol       Date:  2012-05-15       Impact factor: 7.450

2.  Carbamazepine-induced urinary retention.

Authors:  Houssem Hmouda; Chaker Ben Salem; Mounir Grira; Raoudha Slim; Kamel Bouraoui
Journal:  Br J Clin Pharmacol       Date:  2007-12       Impact factor: 4.335

3.  Urinary and fecal incontinence during levetiracetam therapy.

Authors:  Faruk Incecik; Ozlem M Herguner; Seyda Besen; Sakir Altunbasak
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.